FACULTY
Joshua Lang, MD, MSc
Associate Professor
Associate Director of Translation Research
University of Wisconsin
Carbone Cancer Center
Madison, WI
PROGRAM OVERVIEW
This series of five podcasts on multi-cancer early detection technology is geared toward several unique specialty audiences, one each for pulmonologists, OB/GYNs, gastroenterologists, otolaryngologists, and hematology/oncology specialists. The over-arching goals of the program are to review the relevance and need for multi-cancer early detection tests given the gaps in current cancer screening; discuss clinical data and practical use of these tests in specialty practice; and assess ways to discuss MCED testing with patients in a variety of clinical scenarios as these tests continue to become more and more available in the clinic.
TARGET AUDIENCE
This activity is designed to meet the educational needs of gastroenterologists, OB/GYN clinicians, pulmonologists, otolaryngologists/ENTs, hematologist-oncologists, and multidisciplinary clinicians to ensure confidence in discussing multi-cancer early detection tests for population-based screening.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Assess the need for multi-cancer early detection (MCED) technologies given gaps in conventional cancer screening modalities
- Evaluate current clinical data to clarify MCED accuracy as part of a full diagnostic work-up
- Summarize relevant practice points for multi-specialist clinicians discussing MCED testing with patients in specific clinical scenarios
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Speaker | Relationship | Manufacturer |
| Joshua Lang, MD | Consultant | Gilead, Janssen, Pfizer, Foundation Medicine, Astellas, AstraZeneca, Sanofi, 4D Pharma, and Cullgen. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Emmanuella Foucault, Program Coordinator for Med Learning Group, has nothing to disclose.
- Chris Drury, Medical Services for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITY ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to the event at [email protected]
Please listen to the podcast below:
RELEASED DATE: October 31, 2023
EXPIRATION DATE: October 31, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY
Candace Westgate, DO, MPH, FACOG
Founder and Medical Director
Adventist Health Early All-Around Detection (AHEAD) Program
Adventist Health St. Helena
Saint Helena, CA
PROGRAM OVERVIEW
This series of five podcasts on multi-cancer early detection technology is geared toward several unique specialty audiences, one each for pulmonologists, OB/GYNs, gastroenterologists, otolaryngologists, and hematology/oncology specialists. The over-arching goals of the program are to review the relevance and need for multi-cancer early detection tests given the gaps in current cancer screening; discuss clinical data and practical use of these tests in specialty practice; and assess ways to discuss MCED testing with patients in a variety of clinical scenarios as these tests continue to become more and more available in the clinic.
TARGET AUDIENCE
This activity is designed to meet the educational needs of gastroenterologists, OB/GYN clinicians, pulmonologists, otolaryngologists/ENTs, hematologist-oncologists, and multidisciplinary clinicians to ensure confidence in discussing multi-cancer early detection tests for population-based screening.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Assess the need for multi-cancer early detection (MCED) technologies given gaps in conventional cancer screening modalities
- Evaluate current clinical data to clarify MCED accuracy as part of a full diagnostic work-up
- Summarize relevant practice points for multi-specialist clinicians discussing MCED testing with patients in specific clinical scenarios
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Speaker | Relationship | Manufacturer |
| Candace Westgate, DO | Consultant | Grail and Myriad genetics |
| Speakers Bureau | Grail and Myriad genetics |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Emmanuella Foucault, Program Coordinator for Med Learning Group, has nothing to disclose.
- Chris Drury, Medical Services for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITY ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to the event at [email protected]
Please listen to the podcast below:
RELEASED DATE: October 31, 2023
EXPIRATION DATE: October 31, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY
Tiffany A. Glazer, MD, FACS
Associate Professor, Residency Program Director,
Division of Otolaryngology-Head & Neck Surgery,
University of Wisconsin
Madison, WI
PROGRAM OVERVIEW
This series of five podcasts on multi-cancer early detection technology is geared toward several unique specialty audiences, one each for pulmonologists, OB/GYNs, gastroenterologists, otolaryngologists, and hematology/oncology specialists. The over-arching goals of the program are to review the relevance and need for multi-cancer early detection tests given the gaps in current cancer screening; discuss clinical data and practical use of these tests in specialty practice; and assess ways to discuss MCED testing with patients in a variety of clinical scenarios as these tests continue to become more and more available in the clinic.
TARGET AUDIENCE
This activity is designed to meet the educational needs of gastroenterologists, OB/GYN clinicians, pulmonologists, otolaryngologists/ENTs, hematologist-oncologists, and multidisciplinary clinicians to ensure confidence in discussing multi-cancer early detection tests for population-based screening.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Assess the need for multi-cancer early detection (MCED) technologies given gaps in conventional cancer screening modalities
- Evaluate current clinical data to clarify MCED accuracy as part of a full diagnostic work-up
- Summarize relevant practice points for multi-specialist clinicians discussing MCED testing with patients in specific clinical scenarios.
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Speaker | Relationship | Manufacturer |
| Tiffany A. Glazer, MD, FACS | Nothing to disclose. | |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Emmanuella Foucault, Program Coordinator for Med Learning Group, has nothing to disclose.
- Chris Drury, Medical Services for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITY ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to the event at [email protected]
Please listen to the podcast below:
RELEASED DATE: November 09, 2023
EXPIRATION DATE: November 09, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY
Jennifer Weiss, MD, MS
Associate Professor
Division of Gastroenterology and Hepatology
University of Wisconsin School of Medicine
Public Health Director
University of Wisconsin Gastroenterology Genetics Clinic
Madison, WI
PROGRAM OVERVIEW
This series of five podcasts on multi-cancer early detection technology is geared toward several unique specialty audiences, one each for pulmonologists, OB/GYNs, gastroenterologists, otolaryngologists, and hematology/oncology specialists. The over-arching goals of the program are to review the relevance and need for multi-cancer early detection tests given the gaps in current cancer screening; discuss clinical data and practical use of these tests in specialty practice; and assess ways to discuss MCED testing with patients in a variety of clinical scenarios as these tests continue to become more and more available in the clinic.
TARGET AUDIENCE
This activity is designed to meet the educational needs of gastroenterologists, OB/GYN clinicians, pulmonologists, otolaryngologists/ENTs, hematologist-oncologists, and multidisciplinary clinicians to ensure confidence in discussing multi-cancer early detection tests for population-based screening.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Assess the need for multi-cancer early detection (MCED) technologies given gaps in conventional cancer screening modalities
- Evaluate current clinical data to clarify MCED accuracy as part of a full diagnostic work-up
- Summarize relevant practice points for multi-specialist clinicians discussing MCED testing with patients in specific clinical scenarios
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Speaker | Relationship | Manufacturer |
| Jennifer Weiss, MD, MS | Contracted Research | Exact Sciences |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Emmanuella Foucault, Program Coordinator for Med Learning Group, has nothing to disclose.
- Chris Drury, Medical Services for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITY ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to the event at [email protected]
Please listen to the podcast below:
RELEASED DATE: October 31, 2023
EXPIRATION DATE: October 31, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY
Charu Aggarwal, MD, MPH
Leslye M. Heisler Associate Professor of Medicine
University of Pennsylvania
Philadelphia, PA
PROGRAM OVERVIEW
This series of five podcasts on multi-cancer early detection technology is geared toward several unique specialty audiences, one each for pulmonologists, OB/GYNs, gastroenterologists, otolaryngologists, and hematology/oncology specialists. The over-arching goals of the program are to review the relevance and need for multi-cancer early detection tests given the gaps in current cancer screening; discuss clinical data and practical use of these tests in specialty practice; and assess ways to discuss MCED testing with patients in a variety of clinical scenarios as these tests continue to become more and more available in the clinic.
TARGET AUDIENCE
This activity is designed to meet the educational needs of gastroenterologists, OB/GYN clinicians, pulmonologists, otolaryngologists/ENTs, hematologist-oncologists, and multidisciplinary clinicians to ensure confidence in discussing multi-cancer early detection tests for population-based screening.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Assess the need for multi-cancer early detection (MCED) technologies given gaps in conventional cancer screening modalities
- Evaluate current clinical data to clarify MCED accuracy as part of a full diagnostic work-up
- Summarize relevant practice points for multi-specialist clinicians discussing MCED testing with patients in specific clinical scenarios
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.33 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Speaker | Relationship | Manufacturer |
| Charu Aggarwal, MD | Consultant | Genentech, Lilly, Celgene, Merck, Astra Zeneca, Blueprint Genetics, Shionogi, Daiichi Sankyo/ Astra Zeneca, Regeneron/ Sanofi, Eisai, BeiGene, Turning Point, Pfizer, Janssen, and Boehringer Ingelheim. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Emmanuella Foucault, Program Coordinator for Med Learning Group, has nothing to disclose.
- Chris Drury, Medical Services for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITY ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to the event at [email protected]
Please listen to the podcast below:
RELEASED DATE: October 31, 2023
EXPIRATION DATE: October 31, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
